SCHEMBL3763526

SCHEMBL3763526

CC1(C)Cc2c(sc(N3CCOCC3)c2-c2ccnc(-c3cccc(N4CCN(C(=O)O)CC4)c3)c2)C(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.38
HDAC1 Q13547 1/20 0.38
JMJD6 Q6NYC1 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
ATR Q13535 1/20 0.34
STK17B O94768 1/20 0.34
KMO O15229 1/20 0.34
PSEN1 P49768 4/20 0.34
PSEN2 P49810 4/20 0.34
APH1B Q8WW43 4/20 0.34
NCSTN Q92542 4/20 0.34
APH1A Q96BI3 4/20 0.34
PSENEN Q9NZ42 4/20 0.34
PLOD2 O00469 2/20 0.33
PLOD3 O60568 2/20 0.33
PLOD1 Q02809 2/20 0.33
POLQ O75417 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3756048 0.92 KDM4E (0.38) PIK3CDPIK3CAPIK3CBPIK3CGATR
SCHEMBL3752119 0.91 PIK3CD (0.38) PIK3CDPIK3CAPIK3CBPIK3CGSTK17B
SCHEMBL16161738 0.91 HDAC1 (0.38) KDM1AHDAC1JMJD6PIK3CDPIK3CA
SCHEMBL3761788 0.90 HTR7 (0.41) KDM1AHDAC1JMJD6PIK3CDPIK3CA
SCHEMBL3760006 0.89 PRKDC (0.39) KDM1AHDAC1PIK3CDPIK3CAPIK3CB
SCHEMBL3754939 0.88 KDM1A (0.39) KDM1AHDAC1JMJD6PIK3CDPIK3CA
SCHEMBL3765884 0.87 PRKDC (0.41) KDM1AHDAC1PIK3CDPIK3CAPIK3CB
SCHEMBL3760314 0.87 PIK3CD (0.42) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL3764670 0.86 PIK3CA (0.43) PIK3CDPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL16161804 0.86 ATR (0.40) PIK3CDPIK3CAPIK3CBPIK3CGATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA KDM1A 3543/4885HDAC1 669/4885JMJD6 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.